LifeStance Health Group, Inc. (LFST) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
LFST currently has 387M outstanding shares. with limited dilution risk as only 70.7M additional shares (18.3%) are authorized for issuance. The company has minimally diluted shareholders by 3.28% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Aug 07, 2025 |
10-Q filing | 386.7M shares outstanding |
390M | 71M |
| May 07, 2025 |
10-Q filing | 390.7M shares outstanding |
390M | 71M |
| Feb 27, 2025 |
10-K filing | 379.1M shares outstanding |
380M | 71M |
| Nov 07, 2024 |
10-Q filing | 380.4M shares outstanding |
380M | 71M |
| Aug 08, 2024 |
10-Q filing | 379.4M shares outstanding |
380M | 71M |
| May 09, 2024 |
10-Q filing | 376.3M shares outstanding |
380M | 71M |
| Feb 28, 2024 |
10-K filing | 380.7M shares outstanding |
380M | 71M |
| Nov 08, 2023 |
10-Q filing | 378.6M shares outstanding |
380M | 71M |
| Aug 09, 2023 |
10-Q filing | 378.0M shares outstanding |
380M | 71M |
| May 10, 2023 |
10-Q filing | 376.8M shares outstanding |
380M | 71M |
| Mar 09, 2023 |
10-K filing | 376.4M shares outstanding |
380M | 71M |
| Nov 09, 2022 |
10-Q filing | 376.0M shares outstanding |
380M | 71M |
| Aug 10, 2022 |
10-Q filing | 376.2M shares outstanding |
380M | 71M |
| May 11, 2022 |
10-Q filing | 374.3M shares outstanding |
370M | 71M |
| Mar 17, 2022 |
10-K filing | 374.3M shares outstanding |
370M | 71M |
| Nov 10, 2021 |
10-Q filing | 374.1M shares outstanding |
370M | 71M |
| Aug 12, 2021 |
10-Q filing | 374.1M shares outstanding |
370M | 71M |
| Jun 08, 2021 |
S-1/A filing: This S-1/A filing includes information on the offering of 32,800,000 shares of common stock by the company and 7,200,000 shares of common stock by selling stockholders, with an option for underwriters to purchase an additional 6,000,000 shares. The company expects net proceeds of approximately $490.7 million and intends to use approximately $302.7 million to repay debt and the remaining proceeds for general corporate purposes. |
370M | 71M |
| Jun 01, 2021 |
S-1/A filing: This is an S-1/A filing for an initial public offering of common stock by LifeStance Health Group, Inc. The offering includes shares from both the company and selling stockholders, with an option for underwriters to purchase additional shares. The company intends to use the net proceeds from this offering to repay amounts outstanding under the Existing Credit Agreement. |
370M | 40M |
| May 17, 2021 |
S-1 filing: This is an S-1 filing for a common stock offering, including shares offered by the company and selling stockholders. The filing discusses dividend rights, voting rights, preemptive rights, and liquidation rights associated with the common stock. It also mentions preferred stock and the company's dividend policy. The company intends to use the net proceeds from this offering to repay amounts outstanding under the Existing Credit Agreement, and the remaining net proceeds from this offering for general corporate purposes, including working capital, operating expenses and capital expenditures. |
N/A | 0 |